BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23229544)

  • 1. The dual-specificity phosphatase DUSP14 negatively regulates tumor necrosis factor- and interleukin-1-induced nuclear factor-κB activation by dephosphorylating the protein kinase TAK1.
    Zheng H; Li Q; Chen R; Zhang J; Ran Y; He X; Li S; Shu HB
    J Biol Chem; 2013 Jan; 288(2):819-25. PubMed ID: 23229544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation.
    Yang CY; Li JP; Chiu LL; Lan JL; Chen DY; Chuang HC; Huang CY; Tan TH
    J Immunol; 2014 Feb; 192(4):1547-57. PubMed ID: 24403530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF2-mediated Lys63-linked ubiquitination of DUSP14/MKP6 is essential for its phosphatase activity.
    Yang CY; Chiu LL; Tan TH
    Cell Signal; 2016 Jan; 28(1):145-51. PubMed ID: 26521044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
    Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
    Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling.
    Espada CE; St Gelais C; Bonifati S; Maksimova VV; Cahill MP; Kim SH; Wu L
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction.
    Mochida Y; Takeda K; Saitoh M; Nishitoh H; Amagasa T; Ninomiya-Tsuji J; Matsumoto K; Ichijo H
    J Biol Chem; 2000 Oct; 275(42):32747-52. PubMed ID: 10921914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatase holoenzyme PP1/GADD34 negatively regulates TLR response by inhibiting TAK1 serine 412 phosphorylation.
    Gu M; Ouyang C; Lin W; Zhang T; Cao X; Xia Z; Wang X
    J Immunol; 2014 Mar; 192(6):2846-56. PubMed ID: 24534530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation.
    Fan Y; Yu Y; Shi Y; Sun W; Xie M; Ge N; Mao R; Chang A; Xu G; Schneider MD; Zhang H; Fu S; Qin J; Yang J
    J Biol Chem; 2010 Feb; 285(8):5347-60. PubMed ID: 20038579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP19 Inhibits TNF-α- and IL-1β-Triggered NF-κB Activation by Deubiquitinating TAK1.
    Lei CQ; Wu X; Zhong X; Jiang L; Zhong B; Shu HB
    J Immunol; 2019 Jul; 203(1):259-268. PubMed ID: 31127032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.
    Wang S; Yan ZZ; Yang X; An S; Zhang K; Qi Y; Zheng J; Ji YX; Wang PX; Fang C; Zhu XY; Shen LJ; Yan FJ; Bao R; Tian S; She ZG; Tang YD
    Hepatology; 2018 Apr; 67(4):1320-1338. PubMed ID: 29077210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
    Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
    Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WDR34 is a novel TAK1-associated suppressor of the IL-1R/TLR3/TLR4-induced NF-kappaB activation pathway.
    Gao D; Wang R; Li B; Yang Y; Zhai Z; Chen DY
    Cell Mol Life Sci; 2009 Aug; 66(15):2573-84. PubMed ID: 19521662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal inhibition between the transforming growth factor-β-activated kinase 1 (TAK1) and apoptosis signal-regulating kinase 1 (ASK1) mitogen-activated protein kinase kinase kinases and its suppression by TAK1-binding protein 2 (TAB2), an adapter protein for TAK1.
    Kim SY; Shim JH; Chun E; Lee KY
    J Biol Chem; 2012 Jan; 287(5):3381-91. PubMed ID: 22167179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-specificity phosphatase 5 acts as an anti-inflammatory regulator by inhibiting the ERK and NF-κB signaling pathways.
    Seo H; Cho YC; Ju A; Lee S; Park BC; Park SG; Kim JH; Kim K; Cho S
    Sci Rep; 2017 Dec; 7(1):17348. PubMed ID: 29229953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-155-5p accelerates cerebral ischemia-reperfusion injury via targeting DUSP14 by regulating NF-κB and MAPKs signaling pathways.
    Shi Y; Li K; Xu K; Liu QH
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1408-1419. PubMed ID: 32096190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β-triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination.
    Li Q; Yan J; Mao AP; Li C; Ran Y; Shu HB; Wang YY
    Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19341-6. PubMed ID: 22084099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of DUSP14 (dual specificity phosphatase 14) limits osteoarthritis progression by alleviating chondrocyte injury, inflammation and metabolic homeostasis.
    Zhao Z; Yang J; Zhang L; Zhou Y
    Bioengineered; 2021 Dec; 12(1):7495-7507. PubMed ID: 34605731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers.
    Freudlsperger C; Bian Y; Contag Wise S; Burnett J; Coupar J; Yang X; Chen Z; Van Waes C
    Oncogene; 2013 Mar; 32(12):1549-59. PubMed ID: 22641218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation.
    Blonska M; Shambharkar PB; Kobayashi M; Zhang D; Sakurai H; Su B; Lin X
    J Biol Chem; 2005 Dec; 280(52):43056-63. PubMed ID: 16260783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression.
    Yu Y; Ge N; Xie M; Sun W; Burlingame S; Pass AK; Nuchtern JG; Zhang D; Fu S; Schneider MD; Fan J; Yang J
    J Biol Chem; 2008 Sep; 283(36):24497-505. PubMed ID: 18617512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.